Melanoma

Monitor for sunburn risk goes on sale

A monitor developed at the University of Strathclyde in Glasgow for preventing the risk of over exposure to the sun is now available for sale online.

May 08, 2014
popularity not rated yet | comments 1

Merck: New drugs pending approval or in late tests

Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.

May 06, 2014
popularity 5 / 5 (1) | comments 0

Having eczema may reduce your risk of skin cancer

Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour ...

May 06, 2014
popularity 5 / 5 (2) | comments 0

Skin cancer rates five times higher than in 70s

(Medical Xpress)—The rates of people diagnosed with malignant melanoma, the most serious form of skin cancer, are now five times higher than 40 years ago, according to figures announced by Cancer Research ...

Apr 23, 2014
popularity 4.5 / 5 (2) | comments 0

Survival hope for melanoma patients thanks to new vaccine

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

Apr 17, 2014
popularity 5 / 5 (3) | comments 0

AACR: ICMgp100 tolerated, active in advanced melanoma

(HealthDay)—An affinity-enhanced T cell receptor specific for the human leukocyte antigen-A2 restricted melanoma gp 100 peptide fused to an anti-CD3 antibody fragment, IMCgp100, seems promising for advanced ...

Apr 09, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News